Amarillo residents a part of antibody trials

Several Amarillo residents could make a big different in saving people during the early stages of COVID-19. Since August, the Pharmatex research facility has been asking people who have been COVID-19 positive for three days to participate in their double-blind Regeneron antibody trial. These patients either receive a full, limited or placebo of an antibody designed to diminish severe symptoms…

To access content, please login or purchase a subscription.